Luca Bolliger

Keine laufenden Positionen mehr

Consumer Services

Health Technology

Finance

Profil

Mr. Luca Bolliger is a Director-Communications & Business Development at NovImmune SA. Mr. Bolliger was previously employed as Founder by Biopolo Ticino, Fundamental Analyst by BT&T Asset Management Ltd., a Member by Basel Institute for Immunology, and a Portfolio Manager by Hoffmann-La Roche, Inc. He received his undergraduate degree from the Swiss Federal Institute of Technology.

Ehemalige bekannte Positionen von Luca Bolliger

Unternehmen	Position	Ende
Biopolo Ticino	Gründer	-
BT&T Asset Management AG BT&T Asset Management AG Investment ManagersFinance BT&T Asset Management Ltd. (BT&T-AM) is an independent investment management firm which was established by Walter Meier in 1995. Based in Zurich, Switzerland, the firm manages assets for BT&T TimeLife AG, a closed-end mutual fund.	Corporate Officer/Principal	-
Basel Institute for Immunology	Corporate Officer/Principal	-
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Corporate Officer/Principal	-
NOVIMMUNE SA	Public Communications Contact	-

Sehen Sie sich die Erfahrung von Luca Bolliger im Detail an

Ausbildung von Luca Bolliger

Swiss Federal Institute of Technology

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen